Not checked for notices yet.
The in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunity.
Anne Kleijn, Jenneke Kloezeman, Elike Treffers-Westerlaken and 5 more
PLoS ONE · 2014
doi:10.1371/journal.pone.0097495
Cited by papers we hold 1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.